Dr. Ahmed El-Gendy, an Egyptian physicist and winner of the 2026 Marie Curie Award, has announced a pioneering cancer treatment that utilizes magnetic nanoparticles. This innovative approach involves injecting cancer cells with magnetic nanoparticles, which then react to an external magnetic field. The treatment, known as thermotherapy, generates heat to destroy cancer cells. El-Gendy's research focuses on improving the efficiency of this treatment.
The current challenge with thermotherapy is that it requires high doses of nanoparticles to generate sufficient heat, which can lead to undesirable side effects. El-Gendy's team has been working to enhance the properties of the nanoparticles to achieve the required heat with smaller doses. However, experiments on animals showed that even with improved nanoparticles, the generated heat was still insufficient. This led El-Gendy to explore alternative mechanisms to combat tumors.
El-Gendy's research team discovered that applying an external magnetic field in the presence of magnetic nanoparticles inside cancer cells generates a mechanical force. This force creates a mechanical torque that causes the nanoparticles to rotate, disrupting the cell membrane of the cancer cell. This new approach offers a promising avenue for cancer treatment. The team's findings have sparked optimism about the potential of magnetic nanoparticles in cancer therapy.
While the treatment shows promise, El-Gendy emphasizes that it is still in the experimental stage. Further research is needed to understand the mechanism in detail, test it on various types of cancer cells, and study its impact on healthy cells. The team has conducted experiments on mice with prostate and breast cancer models, achieving encouraging results in reducing tumor size.
The next stage of research involves conducting experiments on a larger number of animals, refining the mechanism, and exploring its application on different types of cancer cells. If the results are favorable, El-Gendy plans to seek approval from the US Food and Drug Administration (FDA) to proceed with clinical trials in collaboration with hospitals.
El-Gendy is optimistic that the treatment will be cost-effective if it succeeds in clinical trials. The materials used are not expensive, and the injected doses are extremely small, measured in micrograms. Additionally, the magnetic field can be generated using a device similar to those used in MRI machines, making it a relatively affordable treatment option.
The innovative cancer treatment using magnetic nanoparticles has generated significant interest in the medical community. As research continues, the potential for this treatment to revolutionize cancer therapy becomes increasingly promising. El-Gendy's work has been recognized with the prestigious Marie Curie Award, highlighting the significance of his contributions to the field of cancer research.
Key points
- Dr. Ahmed El-Gendy's innovative cancer treatment uses magnetic nanoparticles to destroy cancer cells.
- The treatment is still in the experimental stage and requires further research before it can be approved for clinical use.
- If successful, the treatment is expected to be cost-effective due to the low cost of materials and the small doses required.
